Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn MoreBrain tumors grow in the cranial cavity and display aggressive growth behavior with a high rate of local recurrence. Accurate tumor grading is paramount as it significantly influences treatment strategies and prognosis. Conventional imaging is not sufficient to accurately distinguish between high-grade and low-grade brain tumors. Alfa Cytology provides specialized imaging omics services customized for brain tumor research.
Diagnostic imaging plays a pivotal role in the timely detection and continuous monitoring of brain tumors, aiding researchers in developing tailored treatment strategies. The integration of omics data and biomedical imaging has significantly propelled the revolution of the diagnosis, therapeutics and prognosis of brain tumors, introducing a novel paradigm for unraveling the complexities of brain tumors.
Fig.1 Various types of imaging data. (Antonelli L., et al., 2019)
A histopathological diagnosis is an invasive approach limited by the specific location of brain tumors, which is unable to assess the heterogeneity of the entire tumor with a pathological diagnosis of local tissues. Alfa Cytology provides our clients with brain tumor imaging omics analysis services that can extract high-throughput quantitative features from animal medical images, capturing the diverse heterogeneity of brain tumors in vivo. By converting this information into high-dimensional data, we enable the exploration of correlations with histological features which reflect the underlying genetic mutations and characteristics of brain tumors.
The extraction of high-throughput features forms the foundation of our imaging omics analysis. Our expertise encompasses the extraction of diverse high-throughput features including but not limited to the following contents.
Sample Preparation
Library Construction
Sequencing
Data Analysis
Other computational imaging features such as local binary pattern (LBP) and scale-invariant feature transform (SIFT) are also applied to image characterization for brain tumors.
Predictive models of clinical outcomes with specific features are built to meet the diverse needs of our clients. Our reliable modeling methods include supervised, semi-supervised and unsupervised learning. The approaches we adopt will be tailored to the type of samples you provide and your specific analysis requirements.
Methods | Description |
Supervised learning | Support vector machines (SVM), lasso logistic regression and random forest. |
Unsupervised learning | K-means algorithm, Gaussian mixture clustering, consensus clustering, etc. |
Semi-supervised learning | Includes an unsupervised feature learning phase and a supervised model training phase. |
Customized
Solutions
In-depth
Analysis
Strong
Expertise
Short
Turnaround
Alfa Cytology helps researchers develop novel diagnosis strategies for brain tumors by offering valuable imaging omics analysis services. We excel at extracting numerous quantitative features from intricate brain imaging arrays. Please don't hesitate to reach out to our staff to discuss and submit your analysis requirements.
Reference